NaviFUS (ROCO:6872) Accounts Payable & Accrued Expense : NT$23.12 Mil (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is NaviFUS Accounts Payable & Accrued Expense?

NaviFUS's quarterly accounts payable & accrued expense declined from Sep. 2024 (NT$25.31 Mil) to Dec. 2024 (NT$22.05 Mil) but then increased from Dec. 2024 (NT$22.05 Mil) to Mar. 2025 (NT$23.12 Mil).

NaviFUS's annual accounts payable & accrued expense declined from Dec. 2022 (NT$19.39 Mil) to Dec. 2023 (NT$18.12 Mil) but then increased from Dec. 2023 (NT$18.12 Mil) to Dec. 2024 (NT$22.05 Mil).

NaviFUS Accounts Payable & Accrued Expense Historical Data

The historical data trend for NaviFUS's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NaviFUS Accounts Payable & Accrued Expense Chart

NaviFUS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

6.21

13.29

19.39

18.12

22.05

NaviFUS Quarterly Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial											12.91	18.65	25.31	22.05	23.12

NaviFUS Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

NaviFUS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NaviFUS Corp (ROCO:6872) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 508, Section 7 , Zhongxiao East Road, 16th Floor, Nangang District, Taipei City, TWN, 103

Website

https://www.navifus.com

NaviFUS Corp is a Biotech company providing novel platform solutions for crossing the blood-brain barrier (BBB) for enhanced oncology drug delivery. Its product, the NaviFUS System, is designed to utilize non-invasive ultrasound energy to enable transient and safe enhancement of BBB permeability to facilitate the transport of small or large molecular CNS drugs to target tumor tissue at high precision for treatment outcomes. Its vision is to cater to CNS disease patients locally and globally by bringing therapeutic ultrasound technology to clinical use.

NaviFUS Headlines

No Headlines